Patients with prostate cancer who are / were treated with hormonal treatment and developed hot flashes as a side effect are offered Acupuncture as an investigational intervention. The treatment is performed twice a week for four weeks, then once a week for the following six weeks

Relief from the hot flashes as determined by the hot flashes scoring system.

Estimated Enrollment:

50

Study Start Date:

January 2006

Estimated Study Completion Date:

July 2010

Eligibility

Ages Eligible for Study:

18 Years and older

Genders Eligible for Study:

Male

Accepts Healthy Volunteers:

No

Criteria

Inclusion Criteria:

Treatment for prostate cancer using hormonal ablation therapy

Average of three or more hot flashes a day

Performance Status (Karnofsky ≥ 60)

Patients must be ≥ 18 years of age

No other clinically significant disease

Signed study-specific consent form prior to study entry

Exclusion Criteria:

Initiation of a new chemotherapy regimen, immunotherapy; or initiation/ cessation of hormonal therapy during the study or for 3 weeks before the start of the study

Pharmacological treatment of hot flashes or use of selective serotonin reuptake inhibitors (unless the dose and patients’ condition have been stable for 4 weeks)

Skin infections

Patients who had acupuncture treatment in the 6 weeks prior to entering the study, or acupuncture given specifically for the treatment of hot flashes in the previous 6 months.

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00421902